Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel Plus Cisplatin in Advanced NSCLC
NCT00319514Phase 2Completed
- Sponsor
- Gachon University Gil Medical Center
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of docetaxel in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Gachon University Gil Medical Center. Primary endpoint: Objective Response Rate. Started Apr 2004; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00319514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319514.